Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 1668 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
 ~ Next article
 ~ Previous article 
 ~ Table of Contents
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (391 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  References

 Article Access Statistics
    Viewed2046    
    Printed62    
    Emailed0    
    PDF Downloaded96    
    Comments [Add]    

Recommend this journal

 


 
CORRESPONDENCE
Year : 2010  |  Volume : 28  |  Issue : 3  |  Page : 269-270
 

Recurrent infections with Aspergillus require exclusion of defects in the phagocyte NADPH oxidase pathway


Path Links Immunology, Scunthorpe General Hospital, Scunthorpe, DN15 7BH, United Kingdom

Date of Submission02-Dec-2009
Date of Acceptance29-Apr-2010
Date of Web Publication17-Jul-2010

Correspondence Address:
S Khan
Path Links Immunology, Scunthorpe General Hospital, Scunthorpe, DN15 7BH
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0255-0857.66483

Rights and Permissions



How to cite this article:
Khan S. Recurrent infections with Aspergillus require exclusion of defects in the phagocyte NADPH oxidase pathway. Indian J Med Microbiol 2010;28:269-70

How to cite this URL:
Khan S. Recurrent infections with Aspergillus require exclusion of defects in the phagocyte NADPH oxidase pathway. Indian J Med Microbiol [serial online] 2010 [cited 2019 Sep 15];28:269-70. Available from: http://www.ijmm.org/text.asp?2010/28/3/269/66483


Dear Editor,

The case report by S. Mohapatra and colleagues on recurrent primary cutaneous aspergillosis with an apparent 'intact immunological status' requires further clarification as neutrophil function tests were not reported. [1] The patient had non-healing ulcer due to Aspergillus niger for 10 years and a defect in the NADPH oxidase pathway should have been excluded. Neutrophils with an intact NADPH oxidase pathway, on appropriate stimulation, reduce the yellow dye nitroblue tetrazolium to an insoluble blue formazan precipitate (NBT test). This does not occur if there is a defect in superoxide generation (chronic granulomatous disease (CGD) patients), and the dye stays yellow.

CGD patients have recurrent infections with catalase producing pathogens (Aspergillus, Staphylococcus, Serratia marcescens, Nocardia species and Burkholderia cepacia). Pneumonia, lymphadenitis, skin/liver/perianal abscesses, osteomyelitis, granulomas causing outlet obstruction, Crohns-like inflammatory bowel disease occur in CGD. [2] Some patients generate low levels of reactive oxidants and NBT test may be normal, so if clinical suspicion of CGD is high the flow cytometry test using dihydrorhodamine 123 is recommended, as it is extremely sensitive for detection of intracellular hydrogen peroxide production. [2] Mutations in the genes encoding gp91 phox account for 65% of CGD (X-linked CGD), and mutations in p22 phox , p47 phox , p67 phox , p40 phox , Rac2 genes account for autosomal recessive cases. Prophylactic trimethoprim-sulfamethoxazole, itraconazole, or interferon gamma therapy (subcutaneous infusions three times a week) are usually enough to prevent infections, and gene therapy is being actively pursued. [3]

The references of cutaneous aspergillosis quoted by Mahapatra et al. also did not report neutrophil function, while two previous reports of cutaneous aspergillosis and alternariosis had underlying X-CGD, both of whom required oral fluconazole for 6-7 months. [4],[5] Collaboration with Immunologists is vital, as correct diagnosis and effective prophylaxis can prevent life threatening infections and timely stem cell transplantation could offer permanent cure.

 
 ~ References Top

1.Mohapatra S, Xess I, Swetha JV, Tanveer N, Asati D, Ramam M, et al. Primary cutaneous aspergillosis due to Aspergillus niger in an immunocompetent patient. Indian J Med Microbiol 2009;27:367-70.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 2000;343:1703-14.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Kang EM, Malech HL. Advances in treatment for chronic granulomatous disease. Immunol Res 2009;43:77-84.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Chatzipanagiotou S, Takou K, Perogamvros A. Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses 1998;41:379-82.  Back to cited text no. 4  [PUBMED]    
5.Uenotsuchi T, Moroi Y, Urabe K, Fukagawa S, Tsuji G, Matsuda T, et al. Cutaneous alternariosis with chronic granulomatous disease. Eur J Dermatol 2005;15:406-8.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  




 

Top
Print this article  Email this article
Previous article Next article

    

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04